Target intelligence / Profile preview

KLC2 antisense RNA 2 (KLC2-AS2)

Target
KLC2-AS2
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript
01

Overview

**KLC2 antisense RNA 2 (KLC2-AS2)** is a natural antisense long non-coding RNA, transcribed from the opposite DNA strand of the KLC2 gene locus[5]. Natural antisense RNAs typically regulate their corresponding sense genes or nearby genomic regions, potentially controlling transcription, mRNA stability, or chromatin accessibility[7]. However, the precise biological role, expression profile, and clinical relevance of KLC2-AS2 remain poorly defined in the current scientific literature[5][7]. There is no evidence that KLC2-AS2 itself encodes a protein or serves as a direct therapeutic target. Notes and caveats: - There are no published studies linking KLC2-AS2 to human diseases or molecular functions beyond its annotation as a natural antisense lncRNA[5][7]. - The gene is distinct from its sense partner, **KLC2**, which is protein-coding and has known disease and molecular roles, including transport in neurons and potential involvement in neurodegeneration and cancer[1][3]. - If you require information for the **KLC2 protein**, that will yield additional disease and functional details, but "KLC2-AS2" specifically refers to the antisense RNA transcript.

02

Mechanism of action

None known (no drugs targeting this RNA; mechanisms of lncRNA action generally can include transcriptional interference, chromatin remodeling, or RNA-RNA interactions, but specifics for KLC2-AS2 are not reported)

03

Biological functions

Regulation of gene expression (general to antisense lncRNAs—direct action by KLC2-AS2 still uncharacterized)Possible chromatin remodeling, transcriptional regulation, RNA stability modulation (general for natural antisense RNAs; direct confirmation for KLC2-AS2 is lacking)
04

Disease associations

Unknown/Other (no disease link is currently established for KLC2-AS2 itself)

Beyond the preview

Go deeper on KLC2 antisense RNA 2 (KLC2-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLC2 antisense RNA 2 (KLC2-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call